The global neuroendoscopy market size accounted for USD 152.93 million in 2023 and is anticipated to rake around USD 260.49 million by 2033, growing at a CAGR of 5.47% from 2024 to 2033.
Key Points
- North America dominated the market with the biggest market share of 34% in 2023.
- Asia Pacific is the fastest-growing region in the market.
- By product, the rigid neuroendoscopes segment has held the largest market share of 68% in 2023.
- By usability, the reusable segment dominated the market with the biggest market share of 85% in 2023.
- By application, the intraventricular neuroendoscopy segment has held the major market share of 52% in 2023.
- By patient, the adult segment led the market with the maximum market share in 2023.
- Based on end-use, the hospital segment has contributed the major market share of 38% in 2023.
The neuroendoscopy market has witnessed significant growth in recent years, driven by advancements in technology, increasing prevalence of neurological disorders, and growing demand for minimally invasive surgical procedures. Neuroendoscopy involves the use of endoscopes to visualize and treat conditions affecting the brain, spinal cord, and surrounding structures. This minimally invasive approach offers several advantages over traditional open surgery, including shorter recovery times, reduced risk of complications, and improved patient outcomes.
Get a Sample: https://www.precedenceresearch.com/sample/4008
The market for neuroendoscopy is fueled by a number of growth factors. Technological advancements have led to the development of high-definition endoscopes, improved imaging modalities, and sophisticated surgical instruments, enabling neurosurgeons to perform complex procedures with greater precision and efficacy. Additionally, the rising prevalence of neurological disorders such as hydrocephalus, brain tumors, and intracranial hemorrhage has increased the demand for neuroendoscopic procedures. Moreover, the growing geriatric population, coupled with increasing awareness about the benefits of minimally invasive surgery, is driving the adoption of neuroendoscopy worldwide.
Neuroendoscopy Market Scope
Report Coverage | Details |
Growth Rate from 2024 to 2033 | CAGR of 5.47% |
Global Market Size in 2023 | USD 152.93 Million |
Global Market Size by 2033 | USD 260.49 Million |
U.S. Market Size in 2023 | USD 36.40 Million |
U.S. Market Size by 2033 | USD 62 Million |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | By Product, By Usability, By Patient, By Application, and By End-Use |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Neuroendoscopy Market Dynamics
Regionally, the neuroendoscopy market exhibits significant variations in terms of adoption rates and market dynamics. North America dominates the global market, driven by the presence of advanced healthcare infrastructure, high healthcare expenditure, and strong R&D activities in the region. Europe is also a key market for neuroendoscopy, owing to the increasing prevalence of neurological disorders and growing acceptance of minimally invasive surgical techniques. In Asia Pacific, rapid urbanization, improving healthcare infrastructure, and rising healthcare expenditure are driving the growth of the neuroendoscopy market.
Several drivers are propelling the growth of the neuroendoscopy market. The increasing incidence of neurological disorders, coupled with the growing aging population, is creating a substantial demand for neuroendoscopic procedures. Moreover, advancements in imaging technology, such as magnetic resonance imaging (MRI) and computed tomography (CT), have improved the diagnostic accuracy of neuroendoscopic procedures, thereby driving their adoption. Additionally, the growing trend towards outpatient surgeries and the shift towards minimally invasive techniques are further fueling the demand for neuroendoscopy.
Despite the numerous growth opportunities, the neuroendoscopy market faces several challenges. Limited reimbursement policies for neuroendoscopic procedures, particularly in developing countries, pose a significant barrier to market growth. Moreover, the high cost of neuroendoscopic equipment and procedures restricts their accessibility, especially in low-income regions. Furthermore, the shortage of skilled neurosurgeons proficient in performing neuroendoscopic procedures hinders market expansion. Addressing these challenges will be crucial for unlocking the full potential of the neuroendoscopy market.
Read Also: Light Sensor Market Size to Worth USD 12.99 Bn by 2033
Recent Developments
- In September 2023, Amrita Hospital, Kochi, India, launched an advanced center of neuroendoscopy. It’s known as the ACNE-Amrita Center for Neuroendoscopy. This launch will help India strengthen its position in the neuroendoscopy market globally.
- In August 2022, a group of U.S. scientists proved neuroendoscopy procedures to be one of the best options of treatment for patients suffering from brain abscesses with remarkable results.
Neuroendoscopy Market Companies
- Foncepi Comercial Exportadora Ltd
- B. Braun
- Karl Storz
- Olympus Corporation
- Stryker
- Medtronic
- Ackermann Instruments GmbH
- Adeor Medical AG
- Clarus Medical LLC
- Machida Endoscope
- Tonglu WANHE Medical Instrument
- Hawk
- Schindler Endoskopie Technologie GmbH
Segments Covered in the Report
By Product
- Rigid Neuroendoscopes
- Flexible Neuroendoscopes
By Usability
- Reusable Neuroendoscopes
- Disposable Neuroendoscopes
By Patient
- Adult
- Pediatric
By Application
- Transnasal Endoscopy
- Intraventricular Endoscopy
- Transcranial Endoscopy
By End-Use
- Hospitals
- Ambulatory Surgical Center
- Diagnostic Center
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
Blog: https://www.dailytechbulletin.com/
Blog: https://www.autoindustrybulletin.com/